Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Trends in Cancer|February 8, 2023
Precision oncology provides opportunities for targeting KRAS-inhibitor resistanceMartin Sattler, Atish Mohanty, Prakash Kulkarni, et al.
Cancers|June 28, 2023
Arising Novel Agents in Lung Cancer: Are Bispecifics and ADCs the New Paradigm?Amanda Reyes, Rebecca Pharaon, Atish Mohanty, et al.
International Journal of Biological Macromolecules|August 5, 2022
Intrinsically disordered BMP4 morphogen and the beak of the finch: Co-option of an ancient axial patterning systemPrakash Kulkarni, Atish Mohanty, Ravi Salgia, et al.
Seminars in Cancer Biology|July 5, 2022
Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeuticsSaumya Srivastava, Atish Mohanty, Arin Nam, et al.
Translational Lung Cancer Research|June 19, 2025
Neoadjuvant tepotinib in stage IIB N0 non-small cell lung carcinoma with MET exon 14 skipping mutation: a case report and review of the literatureAmanda Reyes, Rebecca Pharaon, Atish Mohanty, et al.
Journal of Thoracic Disease|November 4, 2020
Biomarkers in immunotherapy: literature review and future directionsRebecca Pharaon, Maria A Koczywas, Sabrina Salgia, et al.
Carcinogenesis|February 24, 2021
RLIP depletion induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cellsSharad S Singhal, Atish Mohanty, Prakash Kulkarni, et al.
Expert Opinion on Investigational Drugs|March 18, 2020
FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trialsAtish Mohanty, Rebecca R Pharaon, Arin Nam, et al.
International Journal of Biological Macromolecules|January 9, 2022
Co-opting disorder into order: Intrinsically disordered proteins and the early evolution of complex multicellularityPrakash Kulkarni, Amita Behal, Atish Mohanty, et al.
Pageof 5